[Current views on carcinoid and the carcinoid syndrome].
D000433:1-Propanol / Q000627:therapeutic use; D006916:5-Hydroxytryptophan / Q000097:blood; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002276:Carcinoid Tumor / Q000378:metabolism / Q000628:therapy; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000378:metabolism / Q000628:therapy; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D007610:Kallikreins / Q000378:metabolism; D007705:Kinins / Q000097:blood; D008297:Male; D008303:Malignant Carcinoid Syndrome / Q000378:metabolism / Q000628:therapy; D012701:Serotonin / Q000097:blood
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D007705:Kinins; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D000433:1-Propanol; D006916:5-Hydroxytryptophan; D007610:Kallikreins
Sovremennye predstavleniia o kartsinoide i kartsinoidnom sindrome.